Annual Operating Expenses
$158.83 M
+$44.48 M+38.89%
December 31, 2024
Summary
- As of March 12, 2025, EWTX annual total operating expenses is $158.83 million, with the most recent change of +$44.48 million (+38.89%) on December 31, 2024.
- During the last 3 years, EWTX annual operating expenses has risen by +$115.62 million (+267.54%).
- EWTX annual operating expenses is now at all-time high.
Performance
EWTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$45.54 M
+$5.11 M+12.63%
December 31, 2024
Summary
- As of March 12, 2025, EWTX quarterly total operating expenses is $45.54 million, with the most recent change of +$5.11 million (+12.63%) on December 31, 2024.
- Over the past year, EWTX quarterly operating expenses has increased by +$5.11 million (+12.63%).
- EWTX quarterly operating expenses is now at all-time high.
Performance
EWTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
EWTX Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +38.9% | +12.6% |
3 y3 years | +267.5% | +54.6% |
5 y5 years | +1500.5% | +54.6% |
EWTX Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +267.5% | at high | +255.2% |
5 y | 5-year | at high | +1500.5% | at high | +1302.1% |
alltime | all time | at high | +1500.5% | at high | +1302.1% |
Edgewise Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $158.83 M(+38.9%) | $45.54 M(+12.6%) |
Sep 2024 | - | $40.43 M(+6.1%) |
Jun 2024 | - | $38.11 M(+9.7%) |
Mar 2024 | - | $34.75 M(+2.6%) |
Dec 2023 | $114.36 M(+59.6%) | $33.86 M(+15.0%) |
Sep 2023 | - | $29.45 M(+16.2%) |
Jun 2023 | - | $25.34 M(-1.4%) |
Mar 2023 | - | $25.70 M(+16.4%) |
Dec 2022 | $71.66 M | $22.08 M(+20.9%) |
Sep 2022 | - | $18.26 M(+10.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $16.49 M(+11.2%) |
Mar 2022 | - | $14.83 M(+15.6%) |
Dec 2021 | $43.22 M(+151.4%) | $12.82 M(-1.9%) |
Sep 2021 | - | $13.08 M(+25.0%) |
Jun 2021 | - | $10.46 M(+52.5%) |
Mar 2021 | - | $6.86 M(+8.1%) |
Dec 2020 | $17.19 M(+73.2%) | $6.34 M(+74.1%) |
Sep 2020 | - | $3.64 M(-7.9%) |
Jun 2020 | - | $3.96 M(+21.8%) |
Mar 2020 | - | $3.25 M |
Dec 2019 | $9.92 M | - |
FAQ
- What is Edgewise Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual operating expenses year-on-year change?
- What is Edgewise Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly operating expenses year-on-year change?
What is Edgewise Therapeutics annual total operating expenses?
The current annual operating expenses of EWTX is $158.83 M
What is the all time high annual operating expenses for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual total operating expenses is $158.83 M
What is Edgewise Therapeutics annual operating expenses year-on-year change?
Over the past year, EWTX annual total operating expenses has changed by +$44.48 M (+38.89%)
What is Edgewise Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of EWTX is $45.54 M
What is the all time high quarterly operating expenses for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly total operating expenses is $45.54 M
What is Edgewise Therapeutics quarterly operating expenses year-on-year change?
Over the past year, EWTX quarterly total operating expenses has changed by +$5.11 M (+12.63%)